Order results by:
| Issue | Title | |
| Vol 16, No 6 (2024) | Management of patients with cognitive impairment in old age | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Sokolov | ||
| "... Cognitive impairment (CI) is one of the most common disorders in elderly. As the population ages ..." | ||
| Vol 13, No 3 (2021) | Heterogeneity of the mild cognitive impairment syndrome (specialized outpatient service data analysis) | Abstract similar documents |
| A. B. Lokshina, V. V. Zakharov, D. A. Grishina, N. N. Koberskaya, E. A. Mkhitaryan, S. I. Posohov, N. N. Yakhno | ||
| "... Timely diagnosis and optimal management of patients with cognitive impairment (CI) without ..." | ||
| Vol 9, No 1 (2017) | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease | Abstract similar documents |
| G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov | ||
| "... The review presents the data of recent studies dealing with cognitive impairments (CI) in patients ..." | ||
| Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
| "... of cognitive impairment (CI) of varying severity. The main causes of CI are Alzheimer's disease (AD), vascular ..." | ||
| Vol 13, No 2 (2021) | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions | Abstract similar documents |
| V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov | ||
| "... Cognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease ..." | ||
| Vol 9, No 1 (2017) | Combination therapy for cognitive and emotional impairments in patients with arterial hypertension | Abstract similar documents |
| O. D. Ostroumova, E. A. Karavashkina | ||
| Vol 15, No 2 (2023) | Cognitive disorders in amyotrophic lateral sclerosis | Abstract similar documents |
| M. A. Kutlubaev, D. K. Areprintceva, E. V. Pervushina, L. V. Brylev | ||
| Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
| "... Mild cognitive impairment (MCI) is an intermediate stage between normal cognitive function (CF ..." | ||
| Vol 16, No 6 (2024) | Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment | Abstract similar documents |
| D. A. Grishina, Yu. A. Starchina, E. A. Sokolov, V. A. Parfenov | ||
| "... causes of cognitive impairment (CI). The development of dementia is preceded by mild CI (MCI) over ..." | ||
| Vol 14, No 3 (2022) | The prevalence of cognitive impairment and their association with socioeconomic, demographic and anthropometric factors and geriatric syndromes in people over 65 years of age: data from the Russian epidemiological study EVKALIPT | Abstract PDF (Eng) similar documents |
| E. A. Mkhitaryan, N. M. Vorobieva, O. N. Tkacheva, Yu. V. Kotovskaya, N. N. Koberskaya, E. V. Selezneva, L. N. Ovcharova | ||
| "... , to understand the prevalence of cognitive impairment (CI) and to analyze their associations with socioeconomic ..." | ||
| Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
| L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... The development of dementia is preceded by mild cognitive impairment (MCI), the treatment of which ..." | ||
| Vol 7, No 4 (2015) | The clinical spectrum of non-dementia cognitive impairment: Subjective mild-to-moderate disorders | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina, D. O. Gromova, N. E. Ter-Ovanesova, A. V. Tarapovskaya | ||
| "... on the non-dementia stages of brain diseases: moderate, mild, and subjective cognitive impairments. It sets ..." | ||
| Vol 13, No 4 (2021) | Workplace stress and cognitive functions (a population based study of adults aged 25—44 years) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, A. V. Sukhanov, E. A. Gromova, D. O. Panov, D. V. Denisova, I. V. Gagulin, A. V. Gafarova | ||
| Vol 9, No 3 (2017) | Use of computer stimulating programs in patients with post-stroke cognitive impairment | Abstract similar documents |
| S. V. Prokopenko, T. V. Dyadyuk, E. Yu. Mozheyko, A. F. Bezdenezhnykh, T. D. Koryagina, T. S. Anay-Ool | ||
| "... ischemic stroke (IS) in patients with cognitive impairment (CI). Patients and methods. 81 patients aged 40 ..." | ||
| Vol 11, No 1 (2019) | Cognitive impairment in primary hyperparathyroidism | Abstract similar documents |
| N. G. Mokrysheva, Yu. A. Krupinova, E. E. Bibik, G. A. Melnichenko | ||
| "... Cognitive impairment (CI) is a nonclassical manifestation of primary hyperparathyroidism ..." | ||
| Vol 11, No 3 (2019) | Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them? | Abstract similar documents |
| G. R. Tabeeva, E. A. Kirjanova | ||
| "... Cognitive impairment (CI) associated with brain aging is a consequence of disorders varying ..." | ||
| Vol 12, No 3 (2020) | Cerebral structural and functional changes in diabetes mellitus | Abstract similar documents |
| M. V. Matveeva, Yu. G. Samoilova, N. G. Zhukova, I. V. Tolmachev, E. E. Ermak, O. S. Tonkih | ||
| "... as cognitive impairment (CI). Objective: to study cerebral structural and functional changes in patients ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... with post-stroke cognitive impairment. Patients and methods. Examinations were made in 33 patients aged 45 ..." | ||
| Vol 16, No 4 (2024) | Treatment of post-traumatic cognitive disorders and asthenia: results of an observational study | Abstract similar documents |
| P. R. Kamchatnov, O. Yu. Tsarapkina, N. G. Malyukova, A. V. Miretskaya, E. F. Danshina, L. A. Skipetrova, R. A. Cheremin | ||
| "... Post-traumatic cognitive impairment (CI) and asthenia are common, disabling and often ..." | ||
| Vol 9, No 3 (2017) | Chronic pain-associated cognitive impairment | Abstract similar documents |
| N. N. Koberskaya, G. R. Tabeeva | ||
| "... . Cognitive impairment (CI) in patients with different chronic pain syndromes makes a substantial contribution ..." | ||
| Vol 11, No 1 (2019) | Orthostatic hypotension as a modifiable risk factor for cognitive impairment: a literature review | Abstract similar documents |
| O. D. Ostroumova, E. V. Shikh, E. V. Rebrova, A. Yu. Ryazanova | ||
| "... of elderly and senile people around the world. In this age group, the prevalence of cognitive impairment (CI ..." | ||
| Vol 10, No 2 (2018) | Pre-stroke cognitive impairment and its impact on medication adherence | Abstract similar documents |
| E. A. Kovalenko, A. N. Bogolepova | ||
| "... by cognitive impairment (CI). Objective: to identify whether poststroke patients have pre-stroke cognitive ..." | ||
| Vol 15, No 6 (2023) | Association of cognitive impairment and arterial hypertension | Abstract similar documents |
| O. Yu. Isaykina, K. A. Vekhova, G. S. Drobotov, R. A. Takhirov, M. A. Isaykina, V. M. Gorbunov | ||
| "... cognitive impairment (CI) and dementia in old age. At the same time, changes in certain indicators ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... ). Among its non-motor manifestations, cognitive impairment (CI) and emotional disorders play a special ..." | ||
| Vol 14, No 2 (2022) | Cognitive functions and professional status in the open population of Russia/Siberia among adults aged 25–44 years | Abstract PDF (Eng) similar documents |
| A. V. Sukhanov, M. I. Voevoda, E. A. Gromova, D. V. Denisova, V. V. Gafarov | ||
| "... and ETS excluded a greater number of words that did not correspond to the logical series (i.e ..." | ||
| Vol 15, No 1 (2023) | Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem | Abstract similar documents |
| M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, A. A. Kornilova, E. P. Shchukina | ||
| "... performed. The influence of cognitive impairments (CI), background and comorbidities, as well as drug ..." | ||
| Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
| E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
| "... A common tool for detecting mild cognitive impairment (MCI) is the Montreal Cognitive Assessment ..." | ||
| Vol 16, No 1 (2024) | Treatment of cognitive impairment in patients with cerebral infarction in the internal carotid arteries circulation system: results of a multicentre, randomized, double-blind, placebo-controlled clinical trial | Abstract similar documents |
| D. R. Khasanova, A. A. Yakupova, P. R. Kamchatnov, Zh. Yu. Chefranova, E. I. Bogdanov, P. I Pilipenko, N. M. Khasanova | ||
| "... Objective: to evaluate the efficacy and safety of the Prospecta drug in the treatment of cognitive ..." | ||
| Vol 12, No 6 (2020) | Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease | Abstract similar documents |
| I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova | ||
| "... in the severity of non-motor symptoms, including cognitive impairment (CI). It is the PD heterogeneity study ..." | ||
| Vol 16, No 6 (2024) | Pain and cognitive functions – the battle for cognitive reserve | Abstract similar documents |
| L. T. Akhmedzhanova, G. R. Tabeeva, E. V. Mandra | ||
| "... and motivational components can be distinguished. Cognitive impairments (CI), such as attention deficits, memory ..." | ||
| Vol 15, No 5 (2023) | Depressive disorders and their pharmacotherapy in routine clinical practice | Abstract similar documents |
| S. N. Mosolov, V. A. Parfenov, A. V. Amelin, V. E. Medvedev, V. D. Mendelevich, G. M. Usov, Yu. P. Sivolap, A. N. Bogolepova, E. A. Mkhitaryan, D. S. Petelin | ||
| Vol 16, No 5 (2024) | Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease | Abstract similar documents |
| A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova | ||
| "... for the diagnosis and treatment of cognitive impairment (CI). First and foremost, biomarker testing is indicated ..." | ||
| Vol 12, No 5 (2020) | The etiology, manifestations, and therapy of chronic cerebrovascular diseases | Abstract similar documents |
| A. G. Gogoleva, V. V. Zakharov | ||
| "... the clinical manifestations of chronic CVD, primarily vascular cognitive impairment. It discusses international ..." | ||
| Vol 10, No 3 (2018) | Pharmacoeconomic analysis of the use of actovegin in patients with post-stroke cognitive impairment in the health care system of the Russian Federation | Abstract similar documents |
| V. V. Ryazhenov, S. G. Gorokhova, A. V. Knyazev | ||
| "... Post-stroke cognitive impairment (PSCI) is often characterized by a complex prognosis ..." | ||
| Vol 8, No 3 (2016) | Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction | Abstract similar documents |
| I. Ch. Khairullin, R. G. Esin, O. R. Esin | ||
| "... were found to have cognitive impairments (CI): disorders of attention, short-term memory, and thinking ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... fatigue, anxiety and depression disorders (ADDs), and cognitive impairment (CI). Objective: to evaluate ..." | ||
| Vol 12, No 6 (2020) | Computer-based cognitive stimulation for posttraumatic cognitive impairment: a clinical case | Abstract similar documents |
| E. M. Zubritskaya, S. V. Prokopenko, E. Yu. Mozheyko, V. A. Gurevich | ||
| "... for cognitive impairment arising from severe open traumatic brain injury (TBI). It demonstrates ..." | ||
| Vol 16, No 3 (2024) | Cognitive impairment in neuromyelitis optica spectrum disorders | Abstract similar documents |
| E. A. Vekhina, D. S. Kasatkin, S. E. Korchevnyi, K. I. Bereznyak | ||
| "... studies, the prevalence of cognitive impairment (CI) in 761 patients with NMOSD aged 34 to 53 years ..." | ||
| Vol 17, No 3 (2025) | Cognitive impairment in patients with chronic cerebral ischemia (discirculatory encephalopathy) | Abstract similar documents |
| V. A. Parfenov, E. V. Silina | ||
| "... cognitive function (CF) is essential for distinguishing between individuals with and without cognitive ..." | ||
| Vol 11, No 4 (2019) | Refractory status epilepticus syndrome FIRES (febrile infection-related epilepsy syndrome) + NORSE (new-onset refractory status epilepticus): description of a rare clinical case | Abstract similar documents |
| L. R. Akhmadeeva, A. G. Vashkevich, K. V. Bulygin, D. R. Teregulova | ||
| "... development of status epilepticus, cognitive impairment, and pharmacotherapy-resistant epilepsy. The paper ..." | ||
| Vol 15, No 2 (2023) | Management of patients with chronic cerebrovascular disease | Abstract similar documents |
| Yu. A. Starchina, O. V. Kosivtsova, E. A. Sokolov | ||
| "... . Vascular cognitive impairment is the earliest and most objective sign of cerebrovascular pathology ..." | ||
| Vol 10, No 4 (2018) | Sporadic cerebral non-amyloid microangiopathy: pathogenesis, diagnosis, and features of treatment policy | Abstract similar documents |
| A. A. Kulesh, V. E. Drobakha, V. V. Shestakov | ||
| "... of the disease, including cognitive impairment. The problem in the differential diagnosis of SCNAMA and cerebral ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... with chronic cerebrovascular disease (CCVD) and cognitive impairment (CI). Patients and methods. A total of 67 ..." | ||
| Vol 8, No 3 (2016) | Prevention of cerebrovascular diseases and cognitive impairment in psychiatric and neurological practice: A literature review | Abstract similar documents |
| A. G. Merkin, V. A. Kazhin, A. N. Komarov, A. V. Fonarev, V. A. Priyatel, I. A. Nikiforov | ||
| "... , dementia, cognitive impairment, and stroke and outlines some state-of-the-art prevention strategies. ..." | ||
| Vol 15, No 2 (2023) | Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis | Abstract similar documents |
| I. A. Gribacheva, T. F. Popova, E. V. Petrova, A. V. Zvonkova | ||
| Vol 8, No 2 (2016) | Treatment for mixed cognitive impairments and emotional disorders in young and middle-aged patients | Abstract similar documents |
| V. A. Parfenov, E. Yu. Solovyeva, L. M. Antonenko, A. B. Lokshina, T. Gorskaya | ||
| "... with mixed cognitive impairments (CI) and emotional diseases. Patients and methods. An open-label ..." | ||
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... Cardiovascular factors significantly increase the risk of vascular cognitive impairment (VCI ..." | ||
| Vol 10, No 4 (2018) | Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings) | Abstract similar documents |
| V. A. Parfenov, S. A. Zhivolupov, V. V. Zakharov, L. A. Belova, O. V. Lagoda, R. G. Esin, N. V. Vakhnina, I. N. Samartsev | ||
| "... with vascular cognitive impairment (CI), which is regarded in foreign literature as the main manifestation ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents | Abstract similar documents |
| M. D. Bogdanova, T. T. Batysheva, Yu. V. Mikadze, R. Ts. Bembeeva, E. Yu. Volkova | ||
| "... Pediatric-onset multiple sclerosis (MS) can lead to cognitive impairment (CI). In general ..." | ||
| Vol 11, No 4 (2019) | Prognostic significance of moderate cognitive impairment in patients at high and very high cardiovascular risk | Abstract similar documents |
| V. V. Henkel, A. S. Kuznetsova, A. O. Salashenko, E. V. Lebedev, I. I. Shaposhnik | ||
| "... Objective: to assess the prognostic significance of cognitive impairment (CI) detected using ..." | ||
| Vol 16, No 5 (2024) | Asthenia and vascular cognitive impairment in young patients after stroke | Abstract similar documents |
| L. A. Shchepankevich, K. V. Rerikh, M. S. Ponomareva, A. V. Zatynko, E. V. Taneeva | ||
| "... Post-stroke cognitive impairment (PSCI) is found in most patients over 50 years of age. At a young ..." | ||
| Vol 12, No 5 (2020) | Cognitive function dynamics in comorbid patients after angioreconstructive interventions | Abstract PDF (Eng) similar documents |
| M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, E. S. Berdnikovitch, R. B. Medvedev, I. I. Titkova, A. V. Naminov, A. V. Annushkin | ||
| Vol 17, No 2 (2025) | Multitarget transcranial magnetic theta-burst stimulation in the correction of cognitive impairment in patients with progressive multiple sclerosis | Abstract PDF (Eng) similar documents |
| A. Kh. Zabirova, I. S. Bakulin, A. G. Poydasheva, D. Yu. Lagoda, M. N. Zakharova, E. V. Gnedovskaya, N. A. Suponeva, M. A. Piradov | ||
| "... Cognitive impairment (CI) is a common symptom in multiple sclerosis (MS) that significantly ..." | ||
| Vol 10, No 1 (2018) | Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases | Abstract similar documents |
| O. N. Voskresenskaya, N. B. Zakharova, Yu. S. Tarasova, N. E. Tereshkina, V. A. Perepelov, E. M. Perepelova | ||
| "... Cognitive impairment (CI) is a basis for the clinical presentation of chronic cerebral ischemia ..." | ||
| 1 - 54 of 54 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
